The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 17, 2021

Filed:

Jul. 06, 2016
Applicants:

Whitehead Institute for Biomedical Research, Cambridge, MA (US);

The Brigham and Women's Hospital, Inc., Boston, MA (US);

Inventors:

Peter Tsvetkov, Cambridge, MA (US);

Sandro Santagata, West Roxbury, MA (US);

Susan Lindquist, Chestnut Hill, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/574 (2006.01); G01N 33/68 (2006.01); G01N 33/50 (2006.01); A61K 31/713 (2006.01); C12N 15/113 (2010.01); A61P 35/02 (2006.01); A61K 31/69 (2006.01); A61K 31/325 (2006.01);
U.S. Cl.
CPC ...
G01N 33/57426 (2013.01); A61K 31/69 (2013.01); A61K 31/713 (2013.01); A61P 35/02 (2018.01); C12N 15/113 (2013.01); G01N 33/5011 (2013.01); G01N 33/6872 (2013.01); A61K 31/325 (2013.01); A61K 2300/00 (2013.01); C12N 2310/14 (2013.01); C12N 2310/141 (2013.01); C12N 2310/531 (2013.01); G01N 2333/4704 (2013.01);
Abstract

In some aspects, the disclosure provides methods of modulating the level of proteasome inhibitor resistance of a cell, the methods comprising manipulating the level of expression or activity of a subunit of the 19S proteasome in the cell. In some aspects, cells in which the level of a 19S subunit is modulated, e.g., reduced, are provided. In some aspects, methods of identifying agents that reduce proteasome inhibitor resistance are provided. In some aspects, methods of classifying cancers according to predicted proteasome inhibitor resistance are provided. In some aspects, methods of killing or inhibiting proliferation of cancer cells, e.g., proteasome inhibitor resistant cancer cells, are provided. In some aspects, methods of treating cancer, e.g., proteasome inhibitor resistant cancer, are provided.


Find Patent Forward Citations

Loading…